Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
Clinical trial NCT06965309 · TERMINATED
Trial details
- NCT number
- NCT06965309
- Sponsor
- Shenzhen MagicRNA Biotechnology Co., Ltd
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2026-02-11
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.